• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Red cell distribution width to albumin ratio may be a useful prognostic marker in the critical care setting

bySiwen LiuandAlex Chan
July 28, 2025
in Emergency, Hematology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Higher red cell distribution width to albumin ratio (RAR) values were associated nonlinearly with a higher mortality risk.

2. The predictive power of RAR alone was moderate but increased when combined with Sequential Organ Failure Assessment (SOFA) scores. 

Evidence Rating Level: 2 (Good)

Current scoring systems, such as the Sequential Organ Failure Assessment (SOFA), can help predict intensive care unit (ICU) mortality but are often complex and require multiple clinical inputs. Simpler prognostic markers are needed to complement existing tools to improve risk stratification. Red cell distribution width (RDW)-to-albumin ratio (RAR) is a novel composite marker with emerging evidence as a potential predictor of mortality across patients with diseases. However, its role in predicting mortality in the diverse ICU population remains unclear. This study thus examined the role of RAR as a predictor of mortality in ICU patients. This retrospective cohort study used data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database and included ICU patients aged 18-90 who were admitted between 2008 and 2022. The primary outcome was all-cause mortality within 28 days after ICU admission. In total, 24,568 ICU patients were included in the study (median [IQR] age = 66 [54-76] years; females [%] = 10,484 [42.67]). Higher RAR values were nonlinearly associated with a higher 28-day mortality risk (adjusted HR = 1.06, 95% CI 1.05–1.07, P < 0.001) and a significant nonlinear relationship (P < 0.001), with a sharp increase in mortality risk observed when RAR values exceeded approximately 5.0 (P for nonlinearity < 0.001). The predictive power of RAR for 28-day mortality was moderate (area under the curve (AUC) = 0.66, 95% CI 0.65–0.67) but improved when combined with SOFA scores (AUC = 0.74, 95% CI 0.72–0.76). Overall, this study found RAR alone has moderate predictive ability for mortality but increases prognostic accuracy when combined with SOFA scores, highlighting RAR’s potential as an adjunct to mortality risk assessment in the ICU setting. Future studies are needed to validate these findings across diverse populations.

Click to read the study in EJMR

Image: PD

RELATED REPORTS

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

FDA grants priority review for iberdomide-based myeloma regimen

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: critical carehematologyICUsepsis
Previous Post

2MM: AI Roundup – Pancreatic Cancer Prediction Breakthrough, Retinal Stroke Risk Maps, Microsoft’s MAI‑DxO Diagnostic Upset, and Kenya’s AI Consult Real‑World Win [July 28th, 2025]

Next Post

Prophylactic vancomycin may reduce recurrent Clostridioides difficile infection but increases antimicrobial resistance

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Apixaban (eliquis) outperforms Rivaroxaban (xarelto) in venous thromboembolism bleeding risk

April 9, 2026
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Variation noted across pre- and post-marketing studies for FDA approved devices
Hematology

FDA grants priority review for iberdomide-based myeloma regimen

March 6, 2026
Obstetric scoring systems overestimate cases of severe sepsis
Infectious Disease

Fluoxetine may improve hemodynamic status and organ dysfunction in patients with severe sepsis

January 29, 2026
Next Post
American College of Physicians releases principles to guide patient partnership in health care

Prophylactic vancomycin may reduce recurrent Clostridioides difficile infection but increases antimicrobial resistance

Intensive rehabilitation not superior to traditional therapy for arm function after stroke

Early anticoagulation after stroke decreases recurrence without increasing bleeding in patients with atrial fibrillation

Half of parents aware of CT radiation cancer risk

AI scans detect pancreatic cancer years before clinical diagnosis

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric
  • Sparsentan (Filspari) becomes first approved treatment for focal segmental glomerulosclerosis
  • A non-invasive neurostimulation intervention may improve social communication impairment in children with autism spectrum disorder
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.